SIX1 (Homeobox protein SIX1) variants and mutations
SIX1 (also known as Homeobox protein SIX1) is a human protein-coding gene encoding a homeobox protein. It regulates developmental programs in the ear, kidney, craniofacial structures, and skeletal muscle together with EYA-family cofactors. Heterozygous pathogenic variants cause branchio-otic or branchio-oto-renal syndrome with hearing loss and variable branchial or renal abnormalities. This analysis covers 721 SIX1 variants and mutations. Of these, 94% have computational variant effect predictions. Disease context includes Branchio-otic syndrome, autosomal dominant nonsyndromic hearing loss, and branchiootic syndrome. Example SIX1 variants include M1I, M1L, and S2*.
Variant analysis overview
- Gene: SIX1
- Protein: Homeobox protein SIX1
- UniProt accession: Q15475
- Organism: Homo sapiens
- Variants analyzed: 721
- Variant scope: all variants
- Completed: 2026-08-22
Variant and mutation evidence
- Variant composition: 423 unspecified-consequence records; 1 stop retained variant; 1 stop lost; 149 synonymous variants; 123 missense variants; 5 in-frame deletions; 12 frameshift variants; 1 in-frame insertions; 2 splice-region variants; 5 stop-gained variants; 1 substitution
- Prediction scores: 677 variants have prediction scores (94% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Branchio-otic syndrome, autosomal dominant nonsyndromic hearing loss, branchiootic syndrome, branchio-oto-renal syndrome, BOR syndrome, prostate carcinoma, isolated craniosynostosis, hereditary disease, hearing loss disorder, deafness, Nephroblastoma, craniosynostosis.
Protein structure and variant hotspots
- Experimental data: 50 protein positions have experimental scores. Source: SIX1 Homeobox domain domainome 1.0.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable SIX1 variants
Examples include M1I, M1L, S2*, S2L, S2W, M3I, L4P, P5A. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1I (p.Met1Ile), rs2502645118, ClinGen CA389911254, ClinVar RCV002871248, Uncertain significance, Autosomal dominant nonsyndromic hearing loss 23; Branchiootic syndrome 3
- M1L (p.Met1Leu), rs1895013419, ClinGen CA389911261, ClinVar RCV001262831, ClinVar RCV003992483, MetaLR 0.49, MetaSVM -0.20, Conflicting interpretations, Branchiootic syndrome 3; Autosomal dominant nonsyndromic hearing loss 23
- S2* (p.Ser2Ter), NCI-TCGA Cosmic COSV5595, cosmic curated COSV55959, Ensembl rs1895013306, CADD 37.00, Variant assessed as somatic; high impact.
- S2L (p.Ser2Leu), cosmic curated COSV10955, CADD 23.80, PolyPhen-2 0.01
- S2W (p.Ser2Trp), Ensembl rs1895013306, SIFT 0.17
- M3I (p.Met3Ile), TOPMed rs1895013216, CADD 22.50, PolyPhen-2 0.00
- L4P (p.Leu4Pro), NCI-TCGA Cosmic COSV9990, cosmic curated COSV99903, Variant assessed as somatic; moderate impact.
- P5A (p.Pro5Ala), ExAC rs759906473, gnomAD rs759906473, CADD 24.40, PolyPhen-2 0.17
- P5L (p.Pro5Leu), ExAC rs771057416, TOPMed rs771057416, gnomAD rs771057416, CADD 31.00, PolyPhen-2 0.54, Uncertain significance, Autosomal dominant nonsyndromic hearing loss 23; Branchiootic syndrome 3
- P5Q (p.Pro5Gln), rs771057416, ClinGen CA7212872, ClinVar RCV003780491, ExAC rs771057416, CADD 31.00, PolyPhen-2 0.97, Uncertain significance, Branchiootic syndrome 3; Autosomal dominant nonsyndromic hearing loss 23
- S6A (p.Ser6Ala), ExAC rs749690789, TOPMed rs749690789, gnomAD rs749690789, CADD 22.10, PolyPhen-2 0.01
- F7L (p.Phe7Leu), Ensembl rs2140241522, CADD 17.10, PolyPhen-2 0.00
- F7Y (p.Phe7Tyr), gnomAD rs1895012819, CADD 23.90, PolyPhen-2 0.01
- G8A (p.Gly8Ala), ExAC rs778375446, gnomAD rs778375446, CADD 21.40, PolyPhen-2 0.01
- G8V (p.Gly8Val), ExAC rs778375446, gnomAD rs778375446, SIFT 0.00
- T10A (p.Thr10Ala), cosmic curated COSV55959, CADD 24.60, PolyPhen-2 0.04
- T10M (p.Thr10Met), TOPMed rs1417956063, gnomAD rs1417956063, CADD 27.50, PolyPhen-2 0.71
- Q11K (p.Gln11Lys), cosmic curated COSV55959, CADD 23.70, PolyPhen-2 0.11
- E12D (p.Glu12Asp), NCI-TCGA Cosmic COSV9990, cosmic curated COSV99903, CADD 22.40, PolyPhen-2 0.02, Variant assessed as somatic; moderate impact.
- E12K (p.Glu12Lys), rs1167753630, ClinGen CA389911189, ClinVar RCV003223983, gnomAD rs1167753630, CADD 26.90, PolyPhen-2 0.46, Uncertain significance, not provided
- Q13K (p.Gln13Lys), cosmic curated COSV55961, gnomAD rs1480942237, CADD 31.00, PolyPhen-2 0.94
- A15G (p.Ala15Gly), Ensembl rs1895012359
- A15T (p.Ala15Thr), cosmic curated COSV55960
- V17E (p.Val17Glu), rs397515562, ClinGen CA345039, ClinVar RCV002477184, UniProt VAR 064948, AlphaMissense 1.00, MetaLR 0.89, not provided, Branchiootic syndrome 3
- V17M (p.Val17Met), gnomAD rs1197458982, CADD 25.70, PolyPhen-2 0.94
- E19K (p.Glu19Lys), gnomAD rs1490210309, CADD 25.70, PolyPhen-2 0.31
- V20A (p.Val20Ala), gnomAD rs1233578721, CADD 22.70, PolyPhen-2 0.07
- L21P (p.Leu21Pro), gnomAD rs1206708089, CADD 32.00, PolyPhen-2 1.00
- Q22H (p.Gln22His), NCI-TCGA Cosmic COSV5595, NCI-TCGA Cosmic COSV9990, cosmic curated COSV99903, CADD 23.00, PolyPhen-2 0.06, Variant assessed as somatic; moderate impact.
- Q22L (p.Gln22Leu), TOPMed rs1177617020, SIFT 0.01
- Q23E (p.Gln23Glu), gnomAD rs1895011772, CADD 22.60, PolyPhen-2 0.01
- Q23P (p.Gln23Pro), ExAC rs781574148, gnomAD rs781574148, CADD 28.70, PolyPhen-2 0.51
- G24D (p.Gly24Asp), cosmic curated COSV55960, SIFT 0.00
- G24S (p.Gly24Ser), Ensembl rs754869969, CADD 21.70, PolyPhen-2 0.00
- G25* (p.Gly25Ter), gnomAD rs1009804624
- G25E (p.Gly25Glu), gnomAD rs867031506, CADD 27.10, PolyPhen-2 0.93
- G25R (p.Gly25Arg), cosmic curated COSV10630, gnomAD rs1009804624, CADD 29.80, PolyPhen-2 0.95
- N26K (p.Asn26Lys), Ensembl rs1375481520, SIFT 0.11
- L27V (p.Leu27Val), 1000Genomes rs544164466, ExAC rs544164466, TOPMed rs544164466, gnomAD rs544164466, CADD 22.40, PolyPhen-2 0.00
- E28D (p.Glu28Asp), rs146357380, ClinGen CA7212863, ClinVar RCV003140491, ESP rs146357380, CADD 17.60, PolyPhen-2 0.04, Uncertain significance, Autosomal dominant nonsyndromic hearing loss 23
- R29H (p.Arg29His), cosmic curated COSV55959, CADD 26.00, PolyPhen-2 0.42
- R29L (p.Arg29Leu), gnomAD 14-60649104-C-A, CADD 31.00, PolyPhen-2 0.95
- R29G (p.Arg29Gly), gnomAD 14-60649105-G-C, CADD 24.90, PolyPhen-2 0.30
- L30L (p.Leu30Leu), rs1402174239, gnomAD 14-60649100-C-G, CADD 14.20
- G31S (p.Gly31Ser), NCI-TCGA Cosmic COSV5596, cosmic curated COSV55961, Variant assessed as somatic; moderate impact.
- G31V (p.Gly31Val), cosmic curated COSV55959, SIFT 0.00
- G31G (p.Gly31Gly), rs756826384, gnomAD 14-60649097-G-A, CADD 13.60
- R32R (p.Arg32Arg), rs1299424353, gnomAD 14-60649094-C-T, CADD 15.80
- F33L (p.Phe33Leu), ExAC rs764103068, gnomAD rs764103068, CADD 27.50, PolyPhen-2 0.68
- F33S (p.Phe33Ser), NCI-TCGA Cosmic COSV9990, cosmic curated COSV99903, SIFT 0.00, Variant assessed as somatic; moderate impact.
- F33F (p.Phe33Phe), rs764103068, gnomAD 14-60649091-G-A, CADD 15.20
- L34M (p.Leu34Met), cosmic curated COSV55959
- L34L (p.Leu34Leu), rs1895010575, gnomAD 14-60649088-C-T, CADD 13.60
- L34P (p.Leu34Pro), gnomAD 14-60649089-A-G, CADD 32.00, PolyPhen-2 0.99
- L34V (p.Leu34Val), gnomAD 14-60649090-G-C, CADD 26.10, PolyPhen-2 0.56
- W35* (p.Trp35Ter), Ensembl rs1032525136, CADD 37.00
- W35G (p.Trp35Gly), rs2502644837, ClinGen CA389911041, ClinVar RCV003332860, Uncertain significance, not provided
- S36T (p.Ser36Thr), cosmic curated COSV55960
- L37P (p.Leu37Pro), cosmic curated COSV55960, CADD 32.00, PolyPhen-2 0.98
- L37V (p.Leu37Val), TOPMed rs1001409064, gnomAD rs1001409064, CADD 24.10, PolyPhen-2 0.35, Likely benign
- L37L (p.Leu37Leu), rs1001409064, gnomAD 14-60649081-G-A, CADD 14.40
- P38A (p.Pro38Ala), ExAC rs760736490, TOPMed rs760736490, gnomAD rs760736490, CADD 27.40, PolyPhen-2 0.84
- P38S (p.Pro38Ser), ExAC rs760736490, TOPMed rs760736490, gnomAD rs760736490, SIFT 0.00
- P38P (p.Pro38Pro), rs752537825, gnomAD 14-60649076-G-A, CADD 8.89
- P38L (p.Pro38Leu), gnomAD 14-60649077-G-A, CADD 30.00, PolyPhen-2 0.57
- A39S (p.Ala39Ser), rs1431824329, ClinGen CA389911017, ClinVar RCV001935752, gnomAD rs1431824329, AlphaMissense 0.23, MetaLR 0.43, Uncertain significance, Branchiootic syndrome 3; Autosomal dominant nonsyndromic hearing loss 23
- A39T (p.Ala39Thr), gnomAD rs1431824329, AlphaMissense 0.23, MetaLR 0.43, Uncertain significance, Autosomal dominant nonsyndromic hearing loss 23
- A39V (p.Ala39Val), gnomAD 14-60649074-G-A, CADD 23.90, PolyPhen-2 0.02
- C40G (p.Cys40Gly), ExAC rs767478646, gnomAD rs767478646, CADD 23.70, PolyPhen-2 0.02
- C40Y (p.Cys40Tyr), gnomAD 14-60649071-C-T, CADD 23.40, PolyPhen-2 0.03
- D41N (p.Asp41Asn), NCI-TCGA TCGA novel, SIFT 1.00, Uncertain significance, Inborn genetic diseases
- D41D (p.Asp41Asp), gnomAD 14-60649067-G-A, CADD 13.80
- H42Y (p.His42Tyr), TOPMed rs1303484853
- H44A (p.His44Ala), NCI-TCGA TCGA novel, SIFT 0.00, Variant assessed as somatic; high impact.
- H44Q (p.His44Gln), ESP rs149166341, ExAC rs149166341, TOPMed rs149166341, gnomAD rs149166341, CADD 21.30, PolyPhen-2 0.01
- H44R (p.His44Arg), gnomAD rs1480268855, CADD 22.10, PolyPhen-2 0.01
- H44L (p.His44Leu), gnomAD 14-60649059-T-A, CADD 23.30, PolyPhen-2 0.02
- H44P (p.His44Pro), gnomAD 14-60649059-T-G, CADD 24.60, PolyPhen-2 0.01
- H44Y (p.His44Tyr), gnomAD 14-60649060-G-A, CADD 23.10, PolyPhen-2 0.01
- K45N (p.Lys45Asn), NCI-TCGA Cosmic COSV5596, NCI-TCGA Cosmic COSV9990, cosmic curated COSV99903, CADD 21.40, PolyPhen-2 0.00, Variant assessed as somatic; moderate impact.
- K45K (p.Lys45Lys), gnomAD 14-60649055-C-T, CADD 13.90
- N46N (p.Asn46Asn), gnomAD 14-60649052-G-A, CADD 13.60
- E47G (p.Glu47Gly), cosmic curated COSV10955, CADD 32.00, PolyPhen-2 0.98
- E47K (p.Glu47Lys), TOPMed rs1223102250, AlphaMissense 1.00, MetaLR 0.87
- E47Q (p.Glu47Gln), rs1223102250, ClinGen CA389910959, ClinVar RCV003794203, ClinVar RCV006368611, AlphaMissense 1.00, MetaLR 0.87, Uncertain significance, Inborn genetic diseases; Branchiootic syndrome 3; Autosomal dominant nonsyndromi
- E47* (p.Glu47Ter), gnomAD 14-60649051-C-A, CADD 37.00
- S48N (p.Ser48Asn), ExAC rs774637636, gnomAD rs774637636, CADD 23.80, PolyPhen-2 0.12
- S48R (p.Ser48Arg), ExAC rs770875229, gnomAD rs770875229, CADD 23.60, PolyPhen-2 0.38, Uncertain significance, not provided
- S48S (p.Ser48Ser), gnomAD 14-60649046-G-A, CADD 14.60
- S48G (p.Ser48Gly), gnomAD 14-60649048-T-C, CADD 27.20, PolyPhen-2 0.46
- V49I (p.Val49Ile), TOPMed rs904273350, CADD 22.50, PolyPhen-2 0.08
- V49V (p.Val49Val), gnomAD 14-60649043-T-A, CADD 14.00
- L50F (p.Leu50Phe), TOPMed rs1232263034, gnomAD rs1232263034, Uncertain significance, Branchiootic syndrome 3
- L50V (p.Leu50Val), TOPMed rs1232263034, gnomAD rs1232263034, Uncertain significance
- K51N (p.Lys51Asn), gnomAD 14-60649037-C-G, CADD 27.10, PolyPhen-2 0.84
- K51K (p.Lys51Lys), gnomAD 14-60649037-C-T, CADD 14.90
- K51Q (p.Lys51Gln), gnomAD 14-60649039-T-G, CADD 25.30, PolyPhen-2 0.44
- K51* (p.Lys51Ter), gnomAD 14-60649039-T-A, CADD 37.00
- A52V (p.Ala52Val), TOPMed rs1258971434, gnomAD rs1258971434, CADD 32.00, PolyPhen-2 0.78
- A52A (p.Ala52Ala), rs1020503352, gnomAD 14-60649034-G-A, CADD 15.20
- K53E (p.Lys53Glu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- K53R (p.Lys53Arg), gnomAD 14-60649032-T-C, CADD 22.20, PolyPhen-2 0.02
- A54E (p.Ala54Glu), cosmic curated COSV55959, CADD 31.00, PolyPhen-2 0.91
- A54S (p.Ala54Ser), cosmic curated COSV55959
- A54T (p.Ala54Thr), gnomAD rs1261097341, CADD 29.30, PolyPhen-2 0.95
- A54V (p.Ala54Val), cosmic curated COSV10955, NCI-TCGA Cosmic COSV5595, SIFT 0.00, Variant assessed as somatic; moderate impact.
- A54A (p.Ala54Ala), rs150550985, gnomAD 14-60649028-C-T, CADD 14.30
- V55A (p.Val55Ala), TOPMed rs1251187381, gnomAD rs1251187381, CADD 23.60, PolyPhen-2 0.01
- V55M (p.Val55Met), ExAC rs770253091, gnomAD rs770253091, CADD 23.00, PolyPhen-2 0.07
- V55L (p.Val55Leu), gnomAD 14-60649027-C-A, CADD 21.20, PolyPhen-2 0.00
- V56I (p.Val56Ile), cosmic curated COSV10801
- V56L (p.Val56Leu), ExAC rs748718182, TOPMed rs748718182, gnomAD rs748718182, CADD 24.40, PolyPhen-2 0.16
- V56V (p.Val56Val), gnomAD 14-60649022-G-T, CADD 12.20
- V56G (p.Val56Gly), gnomAD 14-60649023-A-C, CADD 32.00, PolyPhen-2 0.88
- V56A (p.Val56Ala), gnomAD 14-60649023-A-G, CADD 25.60, PolyPhen-2 0.26
- A57T (p.Ala57Thr), gnomAD rs1221612141, CADD 25.10, PolyPhen-2 0.28
- F58V (p.Phe58Val), gnomAD 14-60649018-A-C, CADD 32.00, PolyPhen-2 0.97
- F58L (p.Phe58Leu), gnomAD 14-60649018-A-G, CADD 32.00, PolyPhen-2 0.95
- H59Q (p.His59Gln), NCI-TCGA TCGA novel, SIFT 0.00, Variant assessed as somatic; moderate impact.
- H59R (p.His59Arg), rs2502644640, ClinGen CA389910879, ClinVar RCV002641286, CADD 24.90, PolyPhen-2 0.36, Uncertain significance, Inborn genetic diseases
- H59Y (p.His59Tyr), gnomAD rs1371905806, CADD 25.20, PolyPhen-2 0.25, Uncertain significance, Autosomal dominant nonsyndromic hearing loss 23
- R60C (p.Arg60Cys), cosmic curated COSV55960, TOPMed rs1895008880, gnomAD rs1895008880, CADD 32.00, PolyPhen-2 0.68
- R60H (p.Arg60His), TOPMed rs893019043, gnomAD rs893019043, CADD 23.40, SIFT 0.03
- R60R (p.Arg60Arg), rs781519092, gnomAD 14-60649010-G-C, CADD 13.70
- G61C (p.Gly61Cys), TOPMed rs1895008717
- G61S (p.Gly61Ser), NCI-TCGA Cosmic COSV9990, cosmic curated COSV99903, Variant assessed as somatic; moderate impact.
- G61G (p.Gly61Gly), rs890107472, gnomAD 14-60649007-G-A, CADD 14.30
- G61D (p.Gly61Asp), gnomAD 14-60649008-C-T, CADD 27.80, PolyPhen-2 0.69
- G61R (p.Gly61Arg), gnomAD 14-60649009-C-G, CADD 25.00, PolyPhen-2 0.14
- N62H (p.Asn62His), rs2502644593, ClinGen CA389910864, ClinVar RCV003801359, CADD 23.30, PolyPhen-2 0.03, Uncertain significance, Branchiootic syndrome 3; Autosomal dominant nonsyndromic hearing loss 23
- N62N (p.Asn62Asn), gnomAD 14-60649004-G-A, CADD 12.80
- F63L (p.Phe63Leu), gnomAD rs1335186361, CADD 24.80, PolyPhen-2 0.11
- F63F (p.Phe63Phe), rs769018187, gnomAD 14-60649001-G-A, CADD 14.90
- R64C (p.Arg64Cys), NCI-TCGA TCGA novel, TOPMed rs1895008493, CADD 32.00, PolyPhen-2 0.79, Uncertain significance, Inborn genetic diseases; Autosomal dominant nonsyndromic hearing loss 23; Branch
- R64H (p.Arg64His), rs1051653507, ClinGen CA261723226, NCI-TCGA Cosmic COSV5595, cosmic curated COSV55959, CADD 23.60, PolyPhen-2 0.07, Conflicting interpretations, Inborn genetic diseases; Autosomal dominant nonsyndromic hearing loss 23; Branch
- R64P (p.Arg64Pro), TOPMed rs1051653507, gnomAD rs1051653507, CADD 23.70, PolyPhen-2 0.02, Uncertain significance
- R64R (p.Arg64Arg), gnomAD 14-60648998-A-C, CADD 14.50
- R64V (p.Arg64Val), gnomAD 14-60648999-CG-C, CADD 31.00
- R64S (p.Arg64Ser), gnomAD 14-60649000-G-T, CADD 23.20, PolyPhen-2 0.03
- E65Q (p.Glu65Gln), TOPMed rs1463809728, SIFT 0.09
- E65D (p.Glu65Asp), gnomAD 14-60648995-C-G, CADD 22.30, PolyPhen-2 0.05
- L66P (p.Leu66Pro), gnomAD rs1161503372, CADD 32.00, PolyPhen-2 0.99
- L66R (p.Leu66Arg), rs1161503372, ClinGen CA389910830, ClinVar RCV002728488, CADD 32.00, PolyPhen-2 0.98, Uncertain significance, Inborn genetic diseases
- L66L (p.Leu66Leu), gnomAD 14-60648992-G-A, CADD 12.70
- Y67C (p.Tyr67Cys), Ensembl rs1895008256, CADD 32.00, PolyPhen-2 0.98
- K68M (p.Lys68Met), TOPMed rs1293880867, gnomAD rs1293880867, CADD 29.80, SIFT 0.00
- K68R (p.Lys68Arg), TOPMed rs1293880867, gnomAD rs1293880867, CADD 22.90, PolyPhen-2 0.00
- I69S (p.Ile69Ser), Ensembl rs751225628, SIFT 0.00
- I69I (p.Ile69Ile), rs1169502259, gnomAD 14-60648983-G-T, CADD 14.40
- L70M (p.Leu70Met), cosmic curated COSV10955, NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L70R (p.Leu70Arg), rs2140241330, ClinGen CA389910803, ClinVar RCV001756584, Ensembl rs2140241330, AlphaMissense 1.00, MetaLR 0.93, Uncertain significance, not provided
- L70V (p.Leu70Val), ESP rs372978267, ExAC rs372978267, gnomAD rs372978267, CADD 22.90, PolyPhen-2 0.41
- L70L (p.Leu70Leu), rs1350311733, gnomAD 14-60648980-C-T, CADD 14.20
- E71E (p.Glu71Glu), rs919138620, gnomAD 14-60648977-C-T, CADD 14.10
- S72C (p.Ser72Cys), cosmic curated COSV55959
- S72R (p.Ser72Arg), rs778653697, ClinGen CA7212846, ClinVar RCV003328028, ClinVar RCV005227996, CADD 23.90, PolyPhen-2 0.02, Uncertain significance, Autosomal dominant nonsyndromic hearing loss 23; Branchiootic syndrome 3; not pr
- H73P (p.His73Pro), UniProt VAR 064949, CADD 25.60, PolyPhen-2 0.31, Pathogenic, in BOS3
- H73Y (p.His73Tyr), cosmic curated COSV10801
- H73H (p.His73His), gnomAD 14-60648971-G-A, CADD 13.80
- Q74* (p.Gln74Ter), rs2502644465, ClinGen CA389910777, ClinVar RCV003443341, Uncertain significance
- F75L (p.Phe75Leu), rs1291757623, NCI-TCGA Cosmic COSV5596, cosmic curated COSV55960, ClinGen CA389910764, CADD 26.20, PolyPhen-2 0.94, Uncertain significance, not provided
- F75V (p.Phe75Val), cosmic curated COSV99903, SIFT 0.00
- F75F (p.Phe75Phe), rs1291757623, gnomAD 14-60648965-G-A, CADD 14.60
- S76L (p.Ser76Leu), ExAC rs756912951, TOPMed rs756912951, gnomAD rs756912951, CADD 28.50, PolyPhen-2 0.47
- S76W (p.Ser76Trp), ExAC rs756912951, TOPMed rs756912951, gnomAD rs756912951, SIFT 0.06
- S76S (p.Ser76Ser), gnomAD 14-60648962-C-A, CADD 14.60
- S76* (p.Ser76Ter), gnomAD 14-60648963-G-T, CADD 37.00
- P77P (p.Pro77Pro), rs756109319, gnomAD 14-60648959-A-T, CADD 10.40
- P77L (p.Pro77Leu), gnomAD 14-60648960-G-A, CADD 25.50, PolyPhen-2 0.03
- H78Q (p.His78Gln), gnomAD 14-60648956-G-T, CADD 22.10, PolyPhen-2 0.01
- H78L (p.His78Leu), gnomAD 14-60648957-T-A, CADD 23.20, PolyPhen-2 0.01
- H78Y (p.His78Tyr), gnomAD 14-60648958-G-A, CADD 24.30, PolyPhen-2 0.02
- N79D (p.Asn79Asp), ExAC rs752695594, gnomAD rs752695594, CADD 24.90, PolyPhen-2 0.05
- N79S (p.Asn79Ser), ExAC rs767354178, TOPMed rs767354178, gnomAD rs767354178, CADD 22.20, PolyPhen-2 0.02
- N79N (p.Asn79Asn), rs1262130947, gnomAD 14-60648953-G-A, CADD 11.90
- N79H (p.Asn79His), gnomAD 14-60648955-T-G, CADD 23.20, PolyPhen-2 0.05
- H80Y (p.His80Tyr), Ensembl rs1895007176, CADD 28.40, PolyPhen-2 0.57
- H80N (p.His80Asn), gnomAD 14-60648952-G-T, CADD 29.20, PolyPhen-2 0.69
- P81H (p.Pro81His), NCI-TCGA Cosmic COSV5596, cosmic curated COSV55960, SIFT 0.00, Variant assessed as somatic; moderate impact.
- P81S (p.Pro81Ser), ExAC rs759405851, TOPMed rs759405851, gnomAD rs759405851, CADD 23.10, PolyPhen-2 0.01, Uncertain significance, Autosomal dominant nonsyndromic hearing loss 23; Branchiootic syndrome 3
Public SIX1 analysis runs
- SIX1 analysis run — SIX1 (721 variants) — completed 2026-08-22